Info@ThinkPinkRocks.com

Palbociclib extends progression-free survival in advanced breast cancer patients

Palbociclib, an investigational oral medication that works by blocking molecules responsible for cancer cell growth, is well tolerated and extends progression-free survival (PFS) in newly diagnosed, advanced breast cancer patients, including those whose disease has stopped responding to traditional endocrine treatments.

Taken from:
Palbociclib extends progression-free survival in advanced breast cancer patients

Share

Leave a Reply

Solve : *
18 − 6 =